CIP
CMD

Capital Insight Partners’s Cantel Medical Corporation CMD Stock Holding History

Capital Insight Partners’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,276
Closed -$1.09M – 80
2019
Q1 		$1.09M Buy
16,276
+431
+3% +$32.6K 0.98% 46
2018
Q4 		$1.18M Sell
15,845
-65
-0.4% -$5.37K 1.22% 39
2018
Q3 		$1.47M Sell
15,910
-1,943
-11% -$185K 1.29% 34
2018
Q2 		$1.76M Sell
17,853
-56
-0.3% -$6.26K 1.44% 28
2018
Q1 		$2M Buy
17,909
+36
+0.2% +$4.04K 1.63% 23
2017
Q4 		$1.84M Buy
17,873
+104
+0.6% +$10.4K 1.44% 32
2017
Q3 		$1.67M Buy
+17,769
New +$1.4M 1.41% 30

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Capital Insight Partners's CMD Position: Q2 2019 in Review

Capital Insight Partners sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 16,276 shares — an estimated $1.09M sold.

Capital Insight Partners first reported a position in CMD in Q3 2017 and held it in 7 quarters. The position peaked at $2M in Q1 2018. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Capital Insight Partners reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Capital Insight Partners sold 16,276 Cantel Medical Corporation shares in Q2 2019, an estimated $1.09M.
  • Capital Insight Partners first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 7 quarters.
  • Capital Insight Partners's Cantel Medical Corporation position peaked at $2M in Q1 2018.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Capital Insight Partners's 13F filing for Q2 2019, filed 9 Jul 2019.